Carlos A. Parra
Keine laufenden Positionen mehr
Profil
Carlos A.
Parra worked as a Vice President of Quality at Telik, Inc. from 2007 to 2007.
He also worked as a Vice President of Quality at Alexza Pharmaceuticals, Inc. and as a Vice President at Innoviva, Inc. from 2009 to 2011.
Prior to that, he was a Principal and Partner at West Coast Associates of Tampa, Inc. from 2002 to 2002.
Mr. Parra received his undergraduate degree from The University of Texas at Austin.
Ehemalige bekannte Positionen von Carlos A. Parra
| Unternehmen | Position | Ende |
|---|---|---|
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 01.02.2007 |
| West Coast Associates of Tampa, Inc. | Corporate Officer/Principal | 01.01.2002 |
| INNOVIVA, INC. | Corporate Officer/Principal | - |
| ALEXZA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Carlos A. Parra
| The University of Texas at Austin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
| West Coast Associates of Tampa, Inc. | Producer Manufacturing |
